Your position:m.limatoxi.com>>EN>>EN>>Formulation>>Upadatinibs launch accelerated: Crohns disease has simultaneously submitted marketing applications in FDA&EMA>> article
Upadatinibs launch accelerated: Crohns disease has simultaneously submitted marketing applications in FDA&EMA
Editor:xuezhe Clicks:0Date:2022-8-2 17:30:13
Keyword:FDA&EMA
Healthoo Information:
Upadatinibs launch accelerated: Crohns disease has simultaneously submitted marketing applications in FDA&EMA
E-mail:xuezhe@healthoo.com
Tel.:86-10-68032463
Our services:
China Im\Ex data service
Service fees of Chinese Vision
Our service items
Online information introduction
Monthly information
Relative Information
Address: Suite 13F,NO2 Building, FuXing International, TianHua North Street, Yizhuang, Daxing District, Beijing, P.R. China
Tel:+86-10-68032463
Baidu
map